How Will the Influenza Treatment Market Grow? Key Trends and Opportunities for 2025 and Beyond
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the influenza treatment market grown in recent years?
The market size of influenza treatments has seen consistent growth in the past few years. The market, which was valued at $6.6 billion in 2024, is predicted to expand to $6.9 billion in 2025, showing a compound annual growth rate (CAGR) of 4.5%. This exploration in the historic period is linked to a surge in yearly influenza incidents, augmented government sponsorship for influenza studies and readiness initiatives, campaigns informing the public about vaccination, the formation of worldwide influenza observation structures, and the expansion of healthcare amenities.
How is the influenza treatment market size expected to evolve during the forecast period?
The market for influenza treatment is projected to demonstrate a consistent upward trend in the approaching years, reaching a valuation of $8.16 billion in 2029 with a compound annual growth rate (CAGR) of 4.3%. This growth trajectories can be credited to the launch of innovative antiviral drugs and treatment methods, the expansion of immunization schemes, consistent enhancement and growth of healthcare infrastructure, a growing population of the elderly, and the creation of novel therapies. The look ahead period also features key trends such as the movement towards the creation of universal vaccines, the advent of revolutionary vaccine delivery systems, the incorporation of artificial intelligence and big data, advancements in personalized medicine, and a rise in partnerships between pharmaceutical companies.
Get your influenza treatment market report here!
https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report
Which key drivers are propelling the influenza treatment market’s growth?
The influenza treatment market is projected to expand due to the rising occurrence of infectious respiratory diseases. Such illnesses encompass conditions like influenza, measles, or respiratory syncytial virus (RSV) infections, which are transmitted via interactions with an infected person, their bodily fluids, or objects/surfaces they’ve contaminated. The escalating spread of such respiratory infections can be attributed to factors such as overpopulation, insufficient healthcare facilities, misuse of antibiotics, and increased global travel. Influenza treatments, which encompass vaccinations and antiviral medications, are utilized to combat a variety of infectious respiratory diseases, including the flu, COVID-19, and other respiratory viruses. As an illustration, the Centers for Disease Control and Prevention (CDC), a national public health institution in the US, disclosed that the hospitalization rate associated with RSV increased from 2 to 7 per 100,000 people between the weeks ending August 5, 2023 and August 19, 2023. Therefore, the escalating occurrence of infectious respiratory diseases is fueling the growth of the influenza treatment market.
What are the market segments in the influenza treatment industry?
The influenza treatment market covered in this report is segmented –
1) By Product Type: Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products
2) By Route Of Administration: Oral, Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels
Subsegments:
1) By Peramivir: Intravenous Peramivir, Peramivir Injection
2) By Zanamivir: Inhaled Zanamivir, Zanamivir Diskhaler
3) By Oseltamivir Phosphate: Oseltamivir Capsules, Oseltamivir Oral Suspension
4) By Baloxavir Marboxil: Baloxavir Tablets, Baloxavir Granules For Oral Suspension
5) Other Products: Rimantadine, Amantadine
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15832&type=smp
Which leading companies are shaping the growth of the influenza treatment market?
Major companies operating in the influenza treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Fujifilm Holdings Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited., Chugai Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, NATCO Pharma Limited, BioCryst Pharmaceuticals Inc., NanoViricides Inc.
What key trends are currently impacting the influenza treatment market’s development?
Prominent entities in the influenza treatment market are concentrating their efforts on broadening their product range by introducing cutting-edge solutions, such as a single-dose oral drug for influenza treatment, to increase patient adherence, enhance treatment results, and achieve a wider market share. A single-dose oral medication is a type of drug created to address influenza (flu) with just one pill, thus simplifying the treatment plan. For example, in August 2022, Genentech Inc., a biotechnology firm based in the United States, reported the U.S. Food and Drug Administration’s (FDA) endorsement of Xofluza (Baloxavir Marboxil). Xofluza is the first and only single-dose oral drug that presents an effective and convenient method for managing uncomplicated acute influenza in kids aged five to less than 12 years, who have been symptomatic for no more than 48 hours, and for dealing with other respiratory viruses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15832
Which geographic areas are influencing the growth of the influenza treatment market?
North America was the largest region in the influenza treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Point-of-Use Water Treatment Systems Global Market Report 2024
Macular Degeneration Treatment Global Market Report 2024
Post-Harvest Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/post-harvest-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
